Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Total Non-Current Liabilities (2009 - 2026)

Updated

Alnylam Pharmaceuticals' Total Non-Current Liabilities was $4.2 billion in Q2 2026, up 16.4% from $3.6 billion a year earlier and up 3.7% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Alnylam Pharmaceuticals came in at $4.17 billion, up 13.1% from FY2024.

  • Total Non-Current Liabilities shows a five-year compound annual growth rate of 12.1% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $3.69 billion in FY2024 (-1.5%), $3.74 billion in FY2023 (+7.2%), $3.49 billion in FY2022 (+18.1%) and $2.96 billion in FY2021 (+25.6%).
  • The Q2 2026 figure marks the highest quarterly Total Non-Current Liabilities in data going back to Q4 2009.
  • Compared with a year earlier, Total Non-Current Liabilities has increased for four straight quarters, with growth averaging 6.1% over the last eight quarters.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q3 2022 (growth of 29.5%); the worst was Q1 2025 (a decline of 9.6%).
  • Per Business Quant data, ALNY's Total Non-Current Liabilities in the three quarters before Q2 2026 was $4.05 billion (Q1 2026), $4.17 billion (Q4 2025) and $4.18 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 105.99 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 106.45 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -967.00 Mn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 5.92 Bn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 4.20 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.20 Bn
Mar 31, 2026 4.05 Bn
Dec 31, 2025 4.17 Bn
Sep 30, 2025 4.18 Bn
Jun 30, 2025 3.60 Bn
Mar 31, 2025 3.37 Bn
Dec 31, 2024 3.69 Bn
Sep 30, 2024 3.82 Bn
Jun 30, 2024 3.66 Bn
Mar 31, 2024 3.72 Bn
Dec 31, 2023 3.74 Bn
Sep 30, 2023 3.72 Bn
Jun 30, 2023 3.55 Bn
Mar 31, 2023 3.43 Bn
Dec 31, 2022 3.49 Bn
Sep 30, 2022 3.42 Bn
Jun 30, 2022 3.00 Bn
Mar 31, 2022 2.91 Bn
Dec 31, 2021 2.96 Bn
Sep 30, 2021 2.64 Bn
API Access

Alnylam Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ALNY&period=max&api_key=YOUR_API_KEY